Arca
Skip to content

Acne

Drug research and approvals for acne: what is recruiting, what Health Canada authorized, FDA orphan designations and EU medicines. See every condition.

As of Nov 16, 2026, 56 studies of acne are recruiting on ClinicalTrials.gov, Health Canada has authorized 25 drug trials for it since 2013, FDA has 1 approved and 0 open orphan designations naming it, and the EU has 1 authorised medicine for it.

  • Recruiting worldwide: 56
  • Trials authorized in Canada: 25
  • FDA orphan approvals: 1
  • EU medicines: 1

Recruiting Now

Newest start dates first, of 56 recruiting on ClinicalTrials.gov ↗

Trials Authorized in Canada

The 10 newest of 25; search them all in Canada trials
Jul 22, 2026A phase 1/2, randomized, double-blind, placebo-controlled study to evaluate the safety of an acne mrna vaccine candidate in adolescents 12 to 17 years of age…579 – ACNE MRNA VACCINESanofiPending
Jul 11, 2025A phase 1/2, randomized, double-blind, placebo-controlled study to evaluate the safety, efficacy and immunogenicity of an acne mrna vaccine candidate in…579 - ACNE MRNA VACCINESanofiPending
Mar 14, 2025A phase I/ii, randomized, placebo-controlled, multi-arm, dose-finding study to evaluate the safety, efficacy and immunogenicity of an acne mrna vaccine…579 - ACNE MRNA VACCINESanofiPending
Oct 15, 2024A phase 1, randomized, double-blind, sponsor-open, placebo-controlled, dose escalation study to evaluate the safety, tolerability, pharmacokinetics and…PF-07905428PfizerClosed
Apr 27, 2021A phase 2, multicenter, randomized, double-blind, vehicle-controlled, clinical study to compare the safety and efficacy of idp-126 gel to epiduo forte gel…CLINDAMYCIN-BENZOYL-ADAPALENE (IDP-126)Bausch HealthOngoing
Feb 13, 2020Phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group, clinical study comparingCLINDAMYCIN/ BENZOYL/ ADAPALENEBausch HealthClosed
Feb 13, 2020Phase 3, multicenter, randomized, double-blind, vehicle-controlled, parallel-group, clinical study comparing the efficacy and safety of idp-126 gel in the…CLINDAMYCIN-BENZOYL-ADAPALENEBausch HealthClosed
Oct 4, 2019Phase 1, randomized, vehicle-controlled, double-blind study to evaluate the safety, tolerability, pharmacokinetic, and pharmacodynamic effects of repeat…BOS-356BOSTON PHARMACEUTICALS INCClosed
Dec 31, 2018A phase 3, multi-center, randomized, double-blind, vehicle-controlled, 2 arm, parallel group study comparing the safety and efficacy of idp-120 gel and idp-120…IDP-120 (TRETINOIN/ BENZOYL PEROXIDE)Dow Pharmaceutical Sciences, Inc.Ongoing
Dec 31, 2018A phase 3, multi-center, randomized, double-blind, vehicle-controlled, 2 arm, parallel group study comparing the safety and efficacy of idp-120 gel and idp-120…IDP-120 (TRETINOIN/ BENZOYL PEROXIDE)Bausch HealthOngoing

FDA Orphan Designations

Approved first, then open designations, newest first
DateDrugSponsorStatus
Nov 22, 1988MetrogelTreatment of acne rosacea.Galderma Laboratories, Inc.Approved

Medicines Authorised in the EU

Newest first
AuthorisedMedicineHolderEPAR
Oct 17, 2025WinleviclascoteroneCassiopea S.p.A.EMA ↗

Condition names come from Health Canada's trial database. Orphan designations and EU medicines are matched when their indication names the condition as whole words, so a broader or differently worded indication can be missed. Recruiting counts are live from ClinicalTrials.gov's own condition search, refreshed daily. ClinicalTrials.gov, Health Canada Clinical Trials Database, FDA orphan designations, EMA

Logos are each company's own site icon, matched by name through Wikidata.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.